4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-006641
Director bought 3,000 shares at $7.78 ($23,340)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Donenberg Phillip B. Director | 2022-02-02 | Purchase | +3,000 | $7.78 | $23,340 | 3,000 | D |
| Open-market purchases · 3,000 sh · avg $7.78 · $23,340 | |||||||
Loading xslF345X03/doc4.xml…